Cite
HARVARD Citation
Poordad, F. et al. (2019). Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low‐dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis. Journal of viral hepatitis. 26 (8), pp. 1027-1030. [Online].